181 related articles for article (PubMed ID: 17360344)
21. Kinetic assay for high-throughput screening of in vitro transthyretin amyloid fibrillogenesis inhibitors.
Dolado I; Nieto J; Saraiva MJ; Arsequell G; Valencia G; Planas A
J Comb Chem; 2005; 7(2):246-52. PubMed ID: 15762752
[TBL] [Abstract][Full Text] [Related]
22. Potent androgen antagonists based on carborane as a hydrophobic core structure.
Fujii S; Goto T; Ohta K; Hashimoto Y; Suzuki T; Ohta S; Endo Y
J Med Chem; 2005 Jul; 48(14):4654-62. PubMed ID: 16000001
[TBL] [Abstract][Full Text] [Related]
23. Novel iodinated carboranes: synthesis of the 8-iodo-7,9-dicarba-nido-undecaborate anion and 2-iodo-1,7-dicarba-closo-dodecaborane.
Safronov AV; Kabytaev KZ; Jalisatgi SS; Hawthorne MF
Dalton Trans; 2014 Sep; 43(33):12467-9. PubMed ID: 24782077
[TBL] [Abstract][Full Text] [Related]
24. Molecular Modeling of the Interactions between Carborane-Containing Analogs of Indomethacin and Cyclooxygenase-2.
Sárosi MB; Neumann W; Lybrand TP; Hey-Hawkins E
J Chem Inf Model; 2017 Aug; 57(8):2056-2067. PubMed ID: 28632381
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and anti-cancer activity of dinuclear platinum(II) complexes containing bis(thioalkyl)dicarba-closo-dodecaborane(12) ligands.
Woodhouse SL; Ziolkowski EJ; Rendina LM
Dalton Trans; 2005 Sep; (17):2827-9. PubMed ID: 16094469
[TBL] [Abstract][Full Text] [Related]
26. Specific disruption of transthyretin(105-115) fibrilization using "stabilizing" inhibitors of transthyretin amyloidogenesis.
Liang Y; Ore MO; Morin S; Wilson DJ
Biochemistry; 2012 Apr; 51(16):3523-30. PubMed ID: 22482799
[TBL] [Abstract][Full Text] [Related]
27. Potent and selective structure-based dibenzofuran inhibitors of transthyretin amyloidogenesis: kinetic stabilization of the native state.
Petrassi HM; Johnson SM; Purkey HE; Chiang KP; Walkup T; Jiang X; Powers ET; Kelly JW
J Am Chem Soc; 2005 May; 127(18):6662-71. PubMed ID: 15869287
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of stable platinum complexes containing carborane in a carrier group for potential BNCT agents.
Yoo J; Do Y
Dalton Trans; 2009 Jul; (25):4978-86. PubMed ID: 19662290
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of transthyretin amyloid fibril formation by 2,4-dinitrophenol through tetramer stabilization.
Raghu P; Reddy GB; Sivakumar B
Arch Biochem Biophys; 2002 Apr; 400(1):43-7. PubMed ID: 11913969
[TBL] [Abstract][Full Text] [Related]
30. Evaluating the binding selectivity of transthyretin amyloid fibril inhibitors in blood plasma.
Purkey HE; Dorrell MI; Kelly JW
Proc Natl Acad Sci U S A; 2001 May; 98(10):5566-71. PubMed ID: 11344299
[TBL] [Abstract][Full Text] [Related]
31. Kinetic stabilization of an oligomeric protein under physiological conditions demonstrated by a lack of subunit exchange: implications for transthyretin amyloidosis.
Wiseman RL; Green NS; Kelly JW
Biochemistry; 2005 Jun; 44(25):9265-74. PubMed ID: 15966751
[TBL] [Abstract][Full Text] [Related]
32. Development of nonsteroidal anti-inflammatory drug analogs and steroid carboxylates selective for human aldo-keto reductase isoforms: potential antineoplastic agents that work independently of cyclooxygenase isozymes.
Bauman DR; Rudnick SI; Szewczuk LM; Jin Y; Gopishetty S; Penning TM
Mol Pharmacol; 2005 Jan; 67(1):60-8. PubMed ID: 15475569
[TBL] [Abstract][Full Text] [Related]
33. Toward optimization of the linker substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies.
Johnson SM; Connelly S; Wilson IA; Kelly JW
J Med Chem; 2008 Oct; 51(20):6348-58. PubMed ID: 18811132
[TBL] [Abstract][Full Text] [Related]
34. nido-Dicarbaborate Induces Potent and Selective Inhibition of Cyclooxygenase-2.
Neumann W; Xu S; Sárosi MB; Scholz MS; Crews BC; Ghebreselasie K; Banerjee S; Marnett LJ; Hey-Hawkins E
ChemMedChem; 2016 Jan; 11(2):175-8. PubMed ID: 26088701
[TBL] [Abstract][Full Text] [Related]
35. Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model.
Ribeiro CA; Oliveira SM; Guido LF; Magalhães A; Valencia G; Arsequell G; Saraiva MJ; Cardoso I
J Alzheimers Dis; 2014; 39(2):357-70. PubMed ID: 24169237
[TBL] [Abstract][Full Text] [Related]
36. Toward optimization of the second aryl substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies.
Johnson SM; Connelly S; Wilson IA; Kelly JW
J Med Chem; 2009 Feb; 52(4):1115-25. PubMed ID: 19191553
[TBL] [Abstract][Full Text] [Related]
37. Carborane Conjugates with Ibuprofen, Fenoprofen and Flurbiprofen: Synthesis, Characterization, COX Inhibition Potential and In Vitro Activity.
Sonam S; Jelača S; Laube M; Schädlich J; Pietzsch J; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN; Hey-Hawkins E
ChemMedChem; 2024 Jun; ():e202400018. PubMed ID: 38844420
[TBL] [Abstract][Full Text] [Related]
38. Pentafluorosulfanyl-containing flufenamic acid analogs: Syntheses, properties and biological activities.
Hendriks CM; Penning TM; Zang T; Wiemuth D; Gründer S; Sanhueza IA; Schoenebeck F; Bolm C
Bioorg Med Chem Lett; 2015 Oct; 25(20):4437-40. PubMed ID: 26372652
[TBL] [Abstract][Full Text] [Related]
39. Perspective assessment of COX-1 and COX-2 selectivity of nonsteroidal anti-inflammatory drugs from clinical practice: use of genetic function approximation.
Zambre AP; Ganure AL; Shinde DB; Kulkarni VM
J Chem Inf Model; 2007; 47(2):635-43. PubMed ID: 17256838
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and evaluation of anthranilic acid-based transthyretin amyloid fibril inhibitors.
Oza VB; Petrassi HM; Purkey HE; Kelly JW
Bioorg Med Chem Lett; 1999 Jan; 9(1):1-6. PubMed ID: 9990446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
